Theravance Biopharma, Inc. (TBPH)
13.96
-4.99
(-26.33%)
USD |
NASDAQ |
Mar 03, 16:00
13.70
-0.26
(-1.86%)
After-Hours: 20:00
Theravance Biopharma EPS Diluted (Quarterly) : 0.0696 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Integer Holdings Corp. | 1.383 |
| QuidelOrtho Corp. | -1.922 |
| Corcept Therapeutics, Inc. | 0.1994 |
| Nektar Therapeutics | -1.875 |
| Innoviva, Inc. | 1.944 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.615M |
| Revenue (Quarterly) | 19.99M |
| Total Expenses (Quarterly) | 16.38M |
| Enterprise Value | 422.30M |
| Gross Profit Margin (Quarterly) | 92.96% |
| Profit Margin (Quarterly) | 18.08% |
| Earnings Yield | 4.03% |
| Normalized Earnings Yield | 4.029 |